Our previous work demonstrated that the ALDH superfamily, especially 1A3, plays a vital role in malignant behavior and gemcitabine resistance in patients with advanced cholangiocarcinoma [16]. The gene discussed is LDHA; the disease is cholangiocarcinoma.